Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Polymer composites having highly dispersed carbon nanotubes
Method and system for automatic 3-D image creation
Single check memory devices and methods
Method for selective deposition of a semiconductor material
Peer-to-peer, internet protocol telephone system with proxy interface for configuration data
Method for identifying modulators of GPCR GPR1 function
Polymer bonded fibrous coating on dipped rubber articles skin contacting external surface
  Randomly Featured Patents
Combination cracker basket and trash container
Pressurizing pump device, liquid ejection apparatus and method of controlling pressurizing pump
Shock absorber for juvenile vehicle seat tether
Voltage source having preset values for source voltage and internal resistance
Plasma process for surface modification of pyrolitic carbon
Board base apparatus
Heat developable color photographic materials with redox dye releasers
Beverage filling machine
Compounds for a controlled release of active molecules
Multi-panel computer display